{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:12:03Z","timestamp":1787587923225,"version":"build-2736575974"},"reference-count":41,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Obesity"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This analysis aimed to assess the efficacy of setmelanotide over 52\u2009weeks in patients with Bardet\u2010Biedl syndrome (BBS) compared with an external natural history cohort from the international Clinical Registry Investigating BBS (CRIBBS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients with BBS \u2265\u20096\u2009years of age (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200929) treated with setmelanotide for 52\u2009weeks in a phase 3 trial (NCT03746522) and a propensity\u2010score matched external control cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200958) from CRIBBS were included. Responder rate at week 52 was defined as \u2265\u20090.3\u2010point decrease in BMI\n                      <jats:italic>z<\/jats:italic>\n                      \u2010score (patients \u2264\u200918\u2009years) or \u2265\u200910% body weight reduction (adults). Secondary outcomes included changes in BMI, BMI\n                      <jats:italic>z<\/jats:italic>\n                      \u2010score, and body weight.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A significantly greater proportion of patients treated with setmelanotide met the primary endpoint compared with control patients (58.6% vs. 6.9%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). In pediatric patients, 71.4% achieved the primary endpoint vs. 10.7% of controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001); in adults, corresponding numbers were 46.7% vs. 3.3% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Secondary outcomes demonstrated consistent benefits of setmelanotide treatment. Sensitivity analysis using inverse probability of treatment weighting confirmed these findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This indirect comparison provides additional strong evidence that setmelanotide significantly improves weight outcomes in patients with BBS. These findings further support its clinical benefit over 52\u2009weeks in managing obesity associated with BBS.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial Registration:<\/jats:bold>\n                      ClinicalTrials.gov identifier: NCT03746522\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/oby.70125","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:19:53Z","timestamp":1771395593000},"page":"579-587","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Setmelanotide in Bardet\u2010Biedl Syndrome: A 52\u2010Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort"],"prefix":"10.1002","volume":"34","author":[{"given":"Jes\u00fas","family":"Argente","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Pediatric Endocrinology University Hospital Ni\u00f1o Jes\u00fas, Research Institute La Princesa  Madrid Spain"},{"name":"Department of Pediatrics Universidad Aut\u00f3noma de Madrid  Madrid Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n (CIBEROBN), Instituto de Salud Carlos III  Madrid Spain"},{"name":"IMDEA, Food Institute, Campus of International Excellence Universidad Aut\u00f3noma de Madrid (CEIUAM) + Spanish National Research Council (CSIC)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Haqq","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology University of Alberta  Edmonton Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Luca","family":"Schorfheide","sequence":"additional","affiliation":[{"name":"stradoo Gmbh  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Touchot","sequence":"additional","affiliation":[{"name":"Rhythm Pharmaceuticals, Inc.  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Huber","sequence":"additional","affiliation":[{"name":"Rhythm Pharmaceuticals, Inc.  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Wiedemann","sequence":"additional","affiliation":[{"name":"stradoo Gmbh  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Pomeroy","sequence":"additional","affiliation":[{"name":"Marshfield Clinic Research Institute  Marshfield Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Phase 3 BBS Trial Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00023"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2012.115"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1989.tb03378.x"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.30406"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-024-01634-7"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.01.018"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000445061"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S338653"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12703"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.appet.2022.106161"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13915"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.70026"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-025-09984-3"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1731035"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0363"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12836"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060640"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2573"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02602-4"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512693"},{"key":"e_1_2_10_22_1","unstructured":"European Medicines Agency \u201cImcivree Product Information \u201d updated June 3 2025 accessed July 9 2025 https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/imcivree\u2010epar\u2010product\u2010information_en.pdf."},{"key":"e_1_2_10_23_1","unstructured":"\u201cIMCIVREE (Setmelanotide) Prescribing Information \u201d Rhythm Pharmaceuticals Inc. updated December 2024 accessed July 11 2025 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/213793s007lbledt.pdf."},{"key":"e_1_2_10_24_1","unstructured":"Health Canada \u201cImcivree Product Monograph \u201d updated July 12 2023 accessed July 11 2025 https:\/\/pdf.hres.ca\/dpd_pm\/00070511.pdf."},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00277-7"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac150.029"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00273-0"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.70002"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03835-9"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14133"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf483"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073813495959"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.04.002"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03041-z"},{"key":"e_1_2_10_35_1","unstructured":"Member State Coordination Group on Health Technology Assessment \u201cMethodological Guideline for Quantitative Evidence Synthesis: Direct and Indirect Comparisons \u201d updated March 8 2024 accessed July 9 2025 https:\/\/health.ec.europa.eu\/document\/download\/4ec8288e\u20106d15\u201049c5\u2010a490\u2010d8ad7748578f_en?filename=hta_methodological\u2010guideline_direct\u2010indirect\u2010comparisons_en.pdf."},{"key":"e_1_2_10_36_1","unstructured":"J.Pomeroy \u201cClinical Registry Investigating Bardet Biedl Syndrome Foundation (CRIBBS) \u201d accessed July 9 2025 https:\/\/www.bardetbiedl.org\/cribbs."},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.0332"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000437739.71477.ee"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21358"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1214\/09-STS313"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6607"}],"updated-by":[{"DOI":"10.1002\/oby.70194","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000}}],"container-title":["Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/oby.70125","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/oby.70125","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/oby.70125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T11:02:08Z","timestamp":1772967728000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.70125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1002\/oby.70125"],"URL":"https:\/\/doi.org\/10.1002\/oby.70125","archive":["Portico"],"relation":{},"ISSN":["1930-7381","1930-739X"],"issn-type":[{"value":"1930-7381","type":"print"},{"value":"1930-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"2025-09-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}